Standardized Extractables Testing for Single-Use Systems

Standardized Extractables Testing for Single-Use Systems

Single-use technologies (SUT) have evolved into commercial operations and drug manufacturers look for solutions to industrialize its usage in a safe and reliable way.

 

With single-use systems (SUS) adoption, quality ownership involves shared responsibilities between supplier and end user. Additional parts of the supply and quality chain shift to supplier.

 

Join us as we present existing good practices to ensure critical quality attributes (CQAs) of the SUS throughout their life cycle.

 

In this webinar, the fundamental principles of Quality Risk Management (QRM) applied to SUS adoption and validation will be discussed.  In addition, participants will gain an in-depth understanding of how to define an integrity strategy for their critical SUS, as well as on how to safely Pre-Use Post Sterilization Integrity Test (PUPSIT) filters in SUS.  By the conclusion of the session, all attendees should be able to define a risk mitigation strategy for SUS.

Speaker

 

 

Charlotte Masy

Hélène Pora

VP Technical Communication & Regulatory Strategy
Pall Biotech

Hélène has been instrumental in the development of Pall single-use technologies for the last 20 years, while getting heavily involved in manufacturing, quality and regulatory aspects. She has over 30 years of experience working for the biopharmaceutical industry, the last 29 years within Pall Corporation.

 

She speaks regularly at conferences about single-use technology with a strong focus on validation and overall process integration aspects. She is also involved in different industry interested group with a strong focus on BPOG, and she is sitting on the board of BPSA.

 

 

Charlotte Masy

Sarah Jeffkins

Laboratory Manager
Pall Biotech

Sarah Jeffkins has been working in the Biotechnology Industry since 1988 when she joined Beecham Pharmaceuticals (now GSK) as a Fermentation Analyst.

 

During her 29 years working for GSK, she has undertaken a variety of roles within Upstream Operations (Fermentation), Downstream Processing (Extraction & Purification), Analytical and Quality. Sarah also had a role as Analytical Team Leader within a Technical Group where she developed her skills for managing a team, motivating and developing people whilst meeting tough objectives.

 

Sarah became the manager of the Analytical Laboratory at Pall Harbourgate facility in 2018, where she co-ordinates the extractable and leachable testing for Europe.

 

 

Learn how Pall's Accelerator Validation Services Can Support You on Your Validation Journey

Download the brochure to learn more about Pall's depth of validation expertise, consultancy services, testing capabilities and analytical methods

더 Biotech Webinars
Our webinars keep you informed on the latest products and technologies, current industry topics, the latest trends and a range of innovations and solutions to help continuously improve your processes.
May 2021
Overcome Exosome Production Challenges

Biotech | Pall Corporation 웨비나 시리즈

This webinar was recorded by BioPharma Asia and first published on their website. https://biopharma-asia.com. It is made available here by kind permission of BioPharma Asia and the presenters. Scroll down to see a transcript of the webinar question and answer session.

 

Hailed as the “next frontier” in cell therapy and regenerative medicine, exosomes are a type of extracellular vesicle and play a key role in the regulation of the intercellular communication processes.

David Haylock of VivaZome will present on upstream production of angiogenic exosomes using the iCELLis® nano fixed bed bioreactor. This will be followed by a presentation by Roberto Ciboldi of Pall Corporation on a platform solution including cell culture, purification and sterile filtration of exosomes.

Participants will be able to:

 

  • Compare the performance of the iCELLis Nano bioreactor to traditional flasks for exosome production from adherent cell culture
  • Understand how an integrated end to end platform delivers highly   purified and consistently-sized exosomes
  • Discover an innovative cGMP scalable manufacturing platform for   exosomes
시청